NCT01733043View on ClinicalTrials.gov

Sedative Effects in Obstructive Sleep Apnea

PHASE2/PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

November 30, 2015

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Dexmedetomidine

DRUG

Placebo

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT01733043 - Sedative Effects in Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter